98.3k views
18 votes
Glycogen synthetase kinase 3 beta is a protein kinase that has been implicated in many types of cancer. Depending on the cell type, the gene for glycogen synthetase kinase 3 beta (GSK38) can act ether as an oncogene or as a tumor suppressor. Which of the following best predicts how GSK 98 mutations can lead to the development of cancer? A Cells with inactive GSK 38 fail to trigger apoptosis. B Cells with inactive GSK 38 fail to proceed past the G2/M checkpoint. с Cells with overactive GSK 98 are more likely to repair DNA damage. Cells with overactive GSK 38 have longer cell cycles.​

1 Answer

0 votes

Answer:

A Cells with inactive GSK 38 fail to trigger apoptosis

Step-by-step explanation:

Apoptosis is defined as the process of programmed death cell. Tumor cells are capable of evading apoptosis, thereby leading to uncontrolled cell proliferation. Glycogen synthase kinase 3 (GSK-3) is a protein kinase that phosphorylates serine and threonine amino acid residues on different substrates, thus activating different signaling pathways and having different biological functions. The GSK-3-mediated phosphorylation on different substrates may lead to the activation or inactivation of apoptosis depending on the cell type. Thus, GSK-3 has a dual activity and functions as a tumor suppressor and oncoprotein.

User Darronz
by
7.5k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.

9.4m questions

12.2m answers

Categories